Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-25-030774
Filing Date
2025-04-01
Accepted
2025-04-01 20:53:30
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 7582
2 EXHIBIT A tm2511143d1_ex99-a.htm EX-99.(A) 3203
  Complete submission text file 0001104659-25-030774.txt   12592
Mailing Address PO BOX 7338 BERKELEY CA 94707
Business Address
ALAFI CAPITAL CO LLC (Filed by) CIK: 0001216017 (see all company filings)

EIN.: 943359302 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037
Business Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037 858-952-5500
CalciMedica, Inc. (Subject) CIK: 0001534133 (see all company filings)

EIN.: 452120079 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-91725 | Film No.: 25801675
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)